These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29246591)

  • 41. [Intravenous thrombolysis patients with acute ischemic stroke: the analysis of the 100 cases. Part I. Characteristic of the patients and effectiveness of treatment].
    Sobolewski P; Sledzińska M; Szczuchniak W; Hatalska-Zerebiec R; Grzesik M; Sobota A
    Przegl Lek; 2012; 69(6):237-41. PubMed ID: 23094435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [ASPECTS-DWI, arterial occlusion sites and subtype of acute ischemic stroke have a relation with outcome following intravenous rt-PA therapy].
    Idei M; Sasaki T; Tanabe T; Muraoka K; Terada K; Meguro T; Hirotsune N; Nishino S
    No Shinkei Geka; 2012 Jul; 40(7):585-91. PubMed ID: 22728535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does modern ischemic stroke therapy in a large community-based dedicated stroke center improve clinical outcomes? A two-year retrospective study.
    Berlet MH; Stambo GW; Kelley M; Van Epps K; Woeste T; Steffen D
    J Stroke Cerebrovasc Dis; 2014; 23(5):869-78. PubMed ID: 24011839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The potential role of insulin resistance in predicting outcome from intravenous thrombolytic therapy.
    Ali M; Hussein M; Magdy R; Khamis A; Othman AM; Abdelkareem SA; Osama W
    Acta Neurol Belg; 2023 Jun; 123(3):885-892. PubMed ID: 35986887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolic Syndrome Predicts Refractoriness to Intravenous Thrombolysis in Acute Ischemic Stroke.
    Dorado L; Arenillas JF; López-Cancio E; Hernández-Pérez M; Pérez de la Ossa N; Gomis M; Millán M; Granada ML; Galán A; Palomeras E; Dávalos A
    J Stroke Cerebrovasc Dis; 2015 Nov; 24(11):2605-12. PubMed ID: 26363707
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case-control study and a meta-analysis.
    Martinez-Ramirez S; Delgado-Mederos R; Marín R; Suárez-Calvet M; Sáinz MP; Alejaldre A; Vidal-Jordana Á; Martí-Vilalta JL; Martí-Fàbregas J
    J Neurol; 2012 Jan; 259(1):111-8. PubMed ID: 21688044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of obesity on stroke outcome after intravenous thrombolysis.
    Sarikaya H; Elmas F; Arnold M; Georgiadis D; Baumgartner RW
    Stroke; 2011 Aug; 42(8):2330-2. PubMed ID: 21757671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years.
    Mione G; Ducrocq X; Thilly N; Lacour JC; Vespignani H; Richard S
    Geriatr Gerontol Int; 2016 Jul; 16(7):843-9. PubMed ID: 26245693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stroke scale items associated with neurologic deterioration within 24 hours after recombinant tissue plasminogen activator therapy.
    Nanri Y; Yakushiji Y; Hara M; Eriguchi M; Okada R; Yukitake M; Hara H
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1117-24. PubMed ID: 23199533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome.
    Paliwal PR; Ahmad A; Shen L; Yeo LL; Loh PK; Ng KW; Chong VF; Ong BK; Venketasubramanian N; Sinha AK; Teoh HL; Bathla G; Chan BP; Sharma VK
    Cerebrovasc Dis; 2012; 33(5):446-52. PubMed ID: 22456065
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Older age is not related to hemorrhagic transformation and favorable outcomes in patients with wake-up ischemic stroke undergoing intravenous thrombolytic therapy].
    Zhai LP; Chen ZC; Yan SQ; Zhong GL; Zhang S; Xu MJ; Lou M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 44(6):638-44. PubMed ID: 26822046
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low thrombin generation predicts poor prognosis in ischemic stroke patients after thrombolysis.
    Hudák R; Székely EG; Kovács KR; Nagy A; Hofgárt G; Berényi E; Csiba L; Kappelmayer J; Bagoly Z
    PLoS One; 2017; 12(7):e0180477. PubMed ID: 28692682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?
    Hassan AE; Zacharatos H; Hassanzadeh B; El-Gengaihy A; AlKawi A; Shhadeh A; Kirmani JF
    J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):116-20. PubMed ID: 20189087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between Blood Pressure and Outcomes in Acute Ischemic Stroke Patients Administered Lytic Medication in the TIMS-China Study.
    Wu W; Huo X; Zhao X; Liao X; Wang C; Pan Y; Wang Y; Wang Y;
    PLoS One; 2016; 11(2):e0144260. PubMed ID: 26828609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CTP infarct core may predict poor outcome in stroke patients treated with IV t-PA.
    Wu TC; Sitton C; Potter A; Bowry R; Sahota P; Cai C; Hui P; Chen Z; Gonzales N; Barreto A; Lopez G; Grotta JC; Savitz SI
    J Neurol Sci; 2014 May; 340(1-2):165-9. PubMed ID: 24694764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of systemic inflammatory response syndrome in ischemic stroke undergoing systemic thrombolysis with intravenous tissue plasminogen activator.
    Boehme AK; Kapoor N; Albright KC; Lyerly MJ; Rawal PV; Bavarsad Shahripour R; Alvi M; Houston JT; Sisson A; Beasley TM; Alexandrov AW; Alexandrov AV; Miller DW
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e271-6. PubMed ID: 24424334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.